Stay updated on Pembrolizumab in Medullary Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedUpdated to v3.2.0 with an added government operating-status notice; removed the specific topic Medullary thyroid carcinoma (v3.1.0).SummaryDifference2%

- Check29 days agoChange DetectedUpdated the disease name to a streamlined term and bumped the revision to v3.1.0.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed; overall, there are no substantive changes to core content.SummaryDifference0.1%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific medical terms related to medullary thyroid gland carcinoma and the introduction of a new facility name and location. Notably, the version has been updated to v3.0.0.SummaryDifference2%

- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Medullary Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Medullary Thyroid Cancer Clinical Trial page.